title: Three-month outcomes of ziv-aflibercept in the treatment of diabetic macular oedema.
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt. moah384@gmail.com.
authors.forename: Mohammed
authors.initials: M
authors.lastname: Ashraf
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Ahmed A R
authors.initials: AA
authors.lastname: Souka
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Hassan
authors.initials: H
authors.lastname: El Kayal
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Mostafa
authors.initials: M
authors.lastname: El Manhaly
authors.affiliation: Ophthalmology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
authors.forename: Mohamed Hossam
authors.initials: MH
authors.lastname: Abdallah
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor